Program overview

We are excited to share our programme schedule with you. But that’s not all! We cordially invite you to join. This is a unique opportunity to share your research with like-minded professionals and experts in the field. Whether you are a seasoned researcher or just starting out, your insights are valuable! Stay tuned for more detailed information about the programme.

More information on the pre-conference workshop on 19 March.

Register for the Conference Download the program
Print program
Program day 1 Program day 2

Farewell drinks

Time: 17:20 - 19:00 CET

WGS in leukemia diagnostics: to be or not to be?

Time: 16:00 - 16:25 CET
Torsten Haferlach, MLL Munich Leukemia Laboratory, Germany

Routine whole genome sequencing-based cancer diagnostics for care and research in The Netherlands.

Time: 10:00 - 10:10 CET
Edwin Cuppen, Hartwig Medical Foundation, Netherlands

Whole-Genome and Transcriptome Sequencing for Precision Oncology in Germany

Time: 09:50 - 10:00 CET
Stefan Fröhling, DKFZ/NCT, Germany

Closing words

Time: 17:15 - 17:20 CET

Keynote Lecture – CGI-Clinics: Data-driven cancer genome interpretation for clinical decision making

Time: 16:25 - 17:15 CET
Nuria Lopez-Bigas, IRB Spain

(Ultra-) fast deep-learned classification algorithms for diagnosing pediatric CNS and solid tumors

Time: 16:10 - 16:25 CET
Lennart Kester, Princess Maxima Center, Utrecht, The Netherlands

Liquid biopsy in cancer: towards whole genome-based analysis of ctDNA in clinical practice

Time: 14:45 - 15:00 CET
Thomas Kessler, Medical Genetic Center, Munich, Germany

Using AI to Understand Cancer Development

Time: 13:55 - 14:20 CET
Moritz Gerstung, German Cancer Research Center (DKFZ), Germany

BrainChild: a national platform for integrating big data from childhood cancer patients

Time: 13:30 - 13:55 CET
David Gisselsson Nord, Genomic Medicine Sweden and Lund University, Sweden

Session 4: The future perspective: data-driven cancer care

Time: 13:29 - 13:30 CET

Multiomics in the diagnostics of mesenchymal tumors reveals new genetic aberrations

Time: 12:05 - 12:20 CET
Yingbo Lin, Karolinska Institute, Stockholm, Sweden

The temporal evolution of cancer hallmarks

Time: 11:50 - 12:05 CET
Lucie Gourmet, University College London, UK

Navigating whole genomes to improve cancer care

Time: 11:25 - 11:50 CET
Joris van de Haar, NKI-AvL, Netherlands

Molecular markers to guide treatment-decision making in metastatic urothelial cancer

Time: 10:15 - 10:30 CET
J. Alberto Nakauma-Gonzalez, Erasmuc MC, Rotterdam, The Netherlands

Use of genomes and other biomarkers when selecting patients for research

Time: 09:50 - 10:15 CET
Kristoffer Staal Rhorberg, Righospitalet, Denmark

Tracking mutational footprints to study cancer causes

Time: 09:25 - 09:50 CET
Ruben van Boxtel, Princess Máxima Center, Utrecht, The Netherlands

Reception including drinks & walking dinner

Time: 17:30 - 19:30 CET

Keynote Lecture – Myeloid Mayhem, tumour initiation and metastatic progression

Time: 16:40 - 17:30 CET
Charles Swanton, The Francis Crick Institute, UK

Whole genome sequencing improves tissue of origin diagnosis and treatment options for cancer of unknown primary

Time: 16:25 - 16:40 CET
Richard Tothill, University of Melbourne, Australia

WGS in leukemia diagnostics: to be or not to be?

Time: 16:00 - 16:25 CET
Torsten Haferlach, MLL Munich Leukemia Laboratory, Germany

The science behind genomics is driving quality of cancer

Time: 14:50 - 15:15 CET
Emile Voest, NKI-AvL, Netherlands

Genomics in therapeutic proof-of-concept precision cancer medicine platform trials

Time: 14:25 - 14:50 CET
Birgit Geoerger, Gustave Roussy, France

Implementation of an academic clinical decision support system in the routine and in the investigational oncology setting

Time: 14:00 - 14:25 CET
David Tamborero, Karolinska Institute, Sweden

Session 2: The clinical perspective: implementation and impact

Time: 13:59 - 14:00 CET

Ethical aspects of genomic data sharing

Time: 11:50 - 12:10 CET
Eva Winkler, Heidelberg, Germany

How genomes are analysed matters

Time: 11:30 - 11:50 CET
Ivo Gut, CNAG Barcelona, Spain

Routine whole genome sequencing-based cancer diagnostics for care and research in The Netherlands.

Time: 10:00 - 10:10 CET
Edwin Cuppen, Hartwig Medical Foundation, Netherlands

DKFZ/NCT/DKTK MASTER: Whole-Genome and Transcriptome Sequencing for Precision Oncology in Germany

Time: 09:50 - 10:00 CET
Stefan Fröhling, DKFZ/NCT, Germany

Five years with Danish National Genome Center

Time: 09:40 - 09:50 CET
Bettina Lundgren, Danish National Genome Center, Denmark

Implementing WGTS in a regionalised healthcare system

Time: 09:30 - 09:40 CET
Richard Rosenquist Brandell, Genomic Medicine Sweden, Sweden

PFMG2025 – Integrating genomic medicine into the national healthcare system in France

Time: 09:20 - 09:30 CET
Frédérique Nowak, 2025 France Genomic Medicine Initiative, France

WGS in a national cancer personalised medicine program; the Genomics England experience

Time: 09:10 - 09:20 CET
Matthew Brown, Genomics England, UK

Session 1: Current state of the art: Overview of European national cancer whole genome sequencing initiatives and EU 1+MG

Time: 08:59 - 09:00 CET

Clinical utility of long read sequencing for comprehensive analysis of cancer patient genomes

Time: 15:45 - 16:00 CET
Alona Sosinsky, Scientific Director, Genomics England

Coffee/Tea Break (with exhibitors/sponsors)

Time: 15:00 - 15:45 CET

Proteogenomics- connecting cancer genotype to molecular phenotype

Time: 14:20 - 14:45 CET
Janne Lehtiö, Karolinska Institute, Sweden

Lunch Break (with exhibitors/sponsors)

Time: 12:20 - 13:29 CET

Personalized antitumor T-cell therapies targeting neoantigens

Time: 11:00 - 11:25 CET
Alena Gros, Vall d’Hebron Institute of Oncology (VHIO), Spain

Coffee/Tea Break (with exhibitors/sponsors)

Time: 10:30 - 11:00 CET

Clinical genome sequencing in pediatric oncology – the INFORM experience

Time: 09:00 - 09:25 CET
Stefan Pfister, KiTZ Heidelberg, Germany

Session 3: The research perspective: Big data analyses and impact on clinic

Time: 08:30 - 08:59 CET

Registration

Time: 08:30 - 08:59 CET

Reception including drinks & walking dinner

Time: 17:30 - 20:00 CET

Coffee/Tea Break (with exhibitors/sponsors)

Time: 15:15 - 16:00 CET

Poster session

Time: 13:00 - 13:59 CET

Lunch Break (with exhibitors/sponsors)

Time: 12:30 - 12:59 CET

Poster flash talks

Time: 12:10 - 12:30 CET

The 1+MG initiatives on cancer

Time: 11:10 - 11:30 CET
Giovanni Tonon, Università Vita-Salute San Raffaele, Alliance against Cancer, Milan, Italy

Coffee/Tea Break (with exhibitors/sponsors)

Time: 10:40 - 11:09 CET

Panel discussion with previous speakers

Time: 10:10 - 10:40 CET

Presentation national initiatives

Time: 09:00 - 09:09 CET

Welcome by Edwin Cuppen on behalf of program committee plus brief intro about the venue by host organisation

Participating national initiatives

Home › Program
↑
Website and marketing